Truist raised the firm’s price target on RXO Inc. (RXO) to $20 from $18 and keeps a Buy rating on the shares. RXO is one of the best ways to gain exposure to tightening capacity and the eventual recovery in spot rates, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target lowered to $14 from $15 at JPMorgan
- RXO Inc. price target lowered to $21 from $23 at Morgan Stanley
- RXO, Inc. Faces Mixed Performance and Regulatory Challenges: Hold Rating with Cautious Outlook
- RXO Inc. price target raised to $12 from $10 at Susquehanna
- RXO Inc. management to meet with Benchmark